Clinical Trial Update: Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Rebamipide ophthalmic solution for Dry Eye Syndrome has completed. Sponsor: Kubota Vision Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Rebamipide ophthalmic solution (rebamipide)

Snippet

Sponsor: Kubota Vision Inc. | Conditions: Dry Eye Syndrome | Phase 3 | Status: COMPLETED